Patent details
LUC00275 Product Name: Combinaison de rilpivirine ou d'une forme thérapeutiquement équivalente de celle-ci protégée par le brevet de base, telle qu'un sel d'addition pharmaceutiquement acceptable de rilpivirine, y compris le sel d'acide chlorhydrique de rilpivirine, et d'emtricitabine
Basic Information
- Publication number:
- LUC00275
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP201653995
- Legal Status:
- Active
- Application number:
- LUC00275
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/11/737/001-002
- Marketing Authorization Type:
- Marketing Authorization Date:
- 28/11/2011
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 27/07/2022
- First Marketing Authorization date:
- 28/11/2011
- Grant date:
- 12/03/2024
- Activation date:
- 09/08/2022
- Publication date:
- 27/07/2022
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 28/11/2026
- SPC Extension Expiration:
- 28/11/2026
- Rejection date:
- Withdrawal date:
Owner
- From:
- 27/07/2022
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 27/07/2022
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/09
- Publication date:
- 01/08/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/05
- Publication date:
- 03/04/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2024/05
- Publication date:
- 03/04/2024
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- 31/08/2026
- Annual Fee Number:
- 25
- Annual Fee Amount:
- 450 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 25/07/2025
- Last Annual Fee Paid Number:
- 24
- Last Annual Fee Paid Amount:
- 440 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 27/07/2022 | Application Form | 3 |
| 27/07/2022 | Marketing authorization | 4 |
| 27/07/2022 | MA publication | 25 |
| 27/07/2022 | Summary of the product caracteristics | 51 |
| 27/07/2022 | General Document | 10 |
| 27/07/2022 | Incoming Correspondence (Post) | 2 |
| 27/07/2022 | Outgoing Correspondence | 1 |
| 13/03/2024 | Outgoing Correspondence | 1 |
| 26/02/2024 | Outgoing Correspondence | 1 |
| 27/07/2022 | Publication | 1 |
| 12/03/2024 | Publication | 1 |
| 12/03/2024 | Certificate | 1 |